ketamane masterclass

Sorry! This event is now over.

Please submit your details below and we will be in touch regarding the release of future recordings.

April 11-12

Who Will Benefit From This MasterClass Series?

This series is geared for clinicians, physicians, psychotherapists, anesthesiologists, psychiatrists, and advanced practice practitioners including CRNAs, physician assistants, and residents. It will also be valuable for students or laypeople interested in entering the novel ketamine treatment space and those already operating a ketamine practice. Participants will acquire high-yield information and actionable expertise from leading ketamine innovators and veteran practitioners.

What Will You Learn?

There’s a lot of information circulating out there. This MasterClass series will consolidate the most important data, resources, and clinical techniques from today’s leading ketamine treatment experts. In planning this series, we made sure to avoid the trap of teaching just one modality or methodology. Instead, we’re presenting a broad range of focused topics, as well as the legal realities of running a ketamine clinic. The live Q&A will ensure that participants leave each class enriched with deeper understandings relevant to their interests in the field.

Price

The 2-day Ketamine Masterclass costs $395, with a special price of $295 for those who register before March 25th.

If you miss any of the live classes, don’t worry: we’ll be recording all sessions and will send you the replays. 

Sunday, April 11

Speaker

Topic

Jason Wallach

Jason Wallach, Ph.D.

Assistant Professor of Pharmaceutical Sciences at University of the Sciences

11:05 am – 12:35 pm EST 

History, Pharmacology, and Mechanisms of Action

(+ Live Q&A)

In this session you will learn:
  • Brief history of ketamine and related compounds
  • Neuropharmacology of ketamine
  • Ketamine’s activity as an NMDAR antagonist
  • Background on other NMDAR antagonists
  • Differences and similarities between R- and S- ketamine
  • Various hypotheses on ketamine’s antidepressant effects

Abid Nazeer, MD

FOUNDER & PRESIDENT OF ADVANCED PSYCHIATRIC SOLUTIONS CMO PsyTech

12:40 pm – 2:10 pm EST 

 

Screening, Assessment, and Preparation of Patients: How to Track and Monitor Outcomes

(+ Live Q&A)

In this session you will learn:
  • Evidence-based clinical uses of ketamine 
  • Components involved in screening a patient for ketamine including contraindications and cautions 
  • Key principles of informed consent and discharge instructions 
  • Alternative treatment options guidance and how to select the most appropriate ketamine treatment modality with a patient 
  • Treatment strategies involving a patient’s current psychiatric medications in the context of ketamine therapy initiation 
  • How to set up healthy expectations and adequate preparation for patients before, during, and after the treatment course 
  • How to measure and track treatment outcomes
  • Insurance reimbursement options and improving patient access to treatment
Sandhya Prashad MD

Sandhya Prashad, MD

President of American Society of Ketamine Physicians, Psychotherapists & Practitioners

2:15 pm – 3:45 pm EST 

 

Dosing and Administration: Choosing the Best Approach

(+ Live Q&A)

In this session you will learn:
  • Core differences with Spravato (intranasal esketamine)
  • Long term maintenance of dosing and administration
  • Common routes of ketamine administration including clinical effects, advantages, and disadvantages of each 
  • IV ketamine dosing guidelines and supporting research 
  • Logistics of ketamine administration including optimal patient experience and setting
  • Dosing considerations for oral, intramuscular, and intranasal ketamine
  • How to identify the common, benign, serious, and rare side effects of ketamine 
  • What and how to monitor during infusion (discussion of which vitals to monitor, video monitoring option, remote vital monitoring options, etc.) 
  • How to handle special circumstances that arise during administration including anxiety/panic, nausea, high blood pressure, etc.

Monday, April 12

Speaker

Topic

Phil Wolfson MD

Phil Wolfson, MD

Director of Ketamine Training Center

11:00 am – 12:30 pm EST 

The Fantastic Effect of Psychedelic Therapy-Ketamine As a Model

(+ Live Q&A)

In this session you will learn:
  • Ketamine-assisted psychotherapy methodology 
  • Treatment implementation techniques 
  • Overview of basic approaches 
  • Principles of high-dose treatments
  • Underlying philosophy 
  • What makes it unique 
  • Limitations and prospects
  • How to best get trained and certified 

Mark Braunstein, DO

Founder and CEO of Reconcious Medical

Matthew

Matthew Campeau, LPC

Founder and CCO of Reconcious Medical

12:35 pm – 2:05 pm EST 

A Model for Virtual Low Dose Ketamine Enhanced Psychotherapy

(+ Live Q&A)

In this session you will learn:
  • Background research on psycholytic psychotherapy 
  • Background research on low dose ketamine as a mental health treatment
  • Neuropsychological and clinical benefits of low dose ketamine on psychotherapy 
  • Need and advantages of low dose KEP 
  • Screening, monitoring, and safety of low dose KEP 
  • Dosing protocols and treatment paths 
  • Overview of the the low dose KEP session 
  • Case examples 
  • How low dose KEP fits with high dose KAP 
  • Therapist modalities and orientation 
  • Disadvantages and questions for further exploration
Adel

Adele Lafrance, Ph.D.

Psychologist and research scientist at Emotion Science

2:10 pm – 3:40 pm EST 

EFKAP: Emotion-Focused Ketamine Therapy

(+ Live Q&A)

In this session you will learn:
  • A brief overview of KAP models
  • A step-by-step review of the EF-KAP model
  • Research data, clinical vignettes, and video clips 
  • Theoretical principles underlying EF-KAP model 
  • Emotion processing 
  • How to facilitate increasing supportive carer involvement 
  • Overview of short-term EF-KAP protocol 
  • Video review 
  • Review of preliminary research with MDD and AN
Brad Bartlett

Brad Bartlett, Esq.

Senior Legal Counsel / Founder Bartlett Law Practice LLC

3:45 pm – 5:15 pm EST 

Ketamine and the Evolving Legal and Regulatory Framework for Psychedelic Medicines

(+ Live Q&A)

In this session you will learn:
  • A brief overview of the three legal pillars of psychedelics (religion/medicine/states’ rights)
  • Principles of psychedelic medicines and liability
  • Legal and regulatory constraints 
  • Safety practices
  • How to prepare for the worst-case scenario
  • Licensing and registration
  • Navigation of the doctor/patient relationship   

For any questions, student prices and eligibility please email deborah@psytech.biz